Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Mammalian ingredients in atorvastatin?Dyanavel patent expiration?Original guselkumab patent?Remdesivir market trends?Remdesivir api supplier?
See the DrugPatentWatch profile for imvexxy
Imvexxy (estradiol vaginal insert) is sold under product and patent exclusivity rules that can include both patent terms and regulatory exclusivities. The exact “come off patent” date depends on which specific patent(s) cover the product and whether any are listed as expiring later than others. A reliable place to check the specific listed patents and their expected expiration timelines is DrugPatentWatch.com: https://www.drugpatentwatch.com/patent/Imvexxy/ [1]
To get the real-world date, you need the earliest expiring patent that blocks generic or competing products. DrugPatentWatch typically lists the relevant patents tied to the brand and shows their projected expiration dates, which is usually what people mean when they ask “when will it come off patent.” [1]
Even if a patent expires, regulatory exclusivity (created by FDA approval pathways and data protections) can still delay generic competition. Checking the listing for both patent expiration and regulatory exclusivity is the best way to avoid being off by months or years. [1]
[1] https://www.drugpatentwatch.com/patent/Imvexxy/
Other Questions About Imvexxy :